Morrison Jodie Pope

Director at Q32 Bio Inc. · on record since Mar 27, 2024
CEO at Q32 Bio Inc. · on record since Mar 27, 2024
Director at Verve Therapeutics, Inc. · on record since Jun 28, 2024
Director at Eledon Pharmaceuticals, Inc. · on record since Sep 24, 2014
President and CEO at Eledon Pharmaceuticals, Inc. · on record since Sep 24, 2014
Director at KERYX BIOPHARMACEUTICALS INC · on record since Jun 23, 2016
Director at AMERICAN LEARNING Corp · on record since Jun 28, 2017
Interim CEO at KERYX BIOPHARMACEUTICALS INC · on record since May 14, 2018
Director at Akebia Therapeutics, Inc. · on record since Dec 13, 2018

Insider trading activity of Morrison Jodie Pope

Transactions on record: 69; since Sep 24, 2014

Open-market buys: 0

Open-market sells: 8; $696.8K

Companies traded: 6; last filing Aug 27, 2026

Figures computed from official regulatory filings — .

Companies where Morrison Jodie Pope has traded

Q32 Bio Inc.16 tx · $304.4K · Aug 27, 2026
Verve Therapeutics, Inc.4 tx · Jul 28, 2025
AMERICAN LEARNING Corp6 tx · Jun 17, 2022
Akebia Therapeutics, Inc.7 tx · Jun 10, 2019
KERYX BIOPHARMACEUTICALS INC8 tx · Dec 13, 2018
Eledon Pharmaceuticals, Inc.28 tx · $489.1K · Jul 5, 2017

Track record of Morrison Jodie Pope

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Morrison Jodie Pope

Co-insiders of Morrison Jodie Pope

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Q32 Bio Inc.Listing on record	Aug 27, 2026	Sell	-9,845	16.56 USD	$163K	SEC
Q32 Bio Inc.Listing on record	Jul 20, 2026	Award	132,000	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Mar 20, 2026	Award	132,000	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 27, 2026	Sell	-9,896	4.51 USD	$44.6K	SEC
Q32 Bio Inc.Listing on record	Dec 4, 2025	Sell	-22,506	3.46 USD	$77.9K	SEC
Q32 Bio Inc.Listing on record	Aug 28, 2025	Sell	-10,494	1.80 USD	$18.9K	SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-267,541	—	—	SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-42,200	—	—	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 6, 2025	AwardD (derivative)	42,200	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	OtherD (derivative)	-152,700	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	AwardD (derivative)	16,901	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	AwardD (derivative)	152,700	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	Award	132,000	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	OtherD (derivative)	-394,445	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	OtherD (derivative)	-16,901	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	AwardD (derivative)	394,445	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	AwardD (derivative)	152,700	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	OtherD (derivative)	-152,700	0.00 USD	—	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 28, 2024	AwardD (derivative)	267,541	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Mar 27, 2024	AwardD (derivative)	394,445	0.00 USD	—	SEC
AMERICAN LEARNING CorpListing unverified	Jun 17, 2022	AwardD (derivative)	54,500	0.00 USD	—	SEC
AMERICAN LEARNING CorpListing unverified	Jun 17, 2021	AwardD (derivative)	96,000	0.00 USD	—	SEC
AMERICAN LEARNING CorpListing unverified	Jun 18, 2020	AwardD (derivative)	12,500	0.00 USD	—	SEC
AMERICAN LEARNING CorpListing unverified	Jun 21, 2019	AwardD (derivative)	25,000	0.00 USD	—	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2019	AwardD (derivative)	20,100	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Q32 Bio Inc.Listing on record	Aug 27, 2026	Sell	-9,845	16.56 USD	$163K	SEC
Q32 Bio Inc.Listing on record	Jul 20, 2026	Award	132,000	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Mar 20, 2026	Award	132,000	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 27, 2026	Sell	-9,896	4.51 USD	$44.6K	SEC
Q32 Bio Inc.Listing on record	Dec 4, 2025	Sell	-22,506	3.46 USD	$77.9K	SEC
Q32 Bio Inc.Listing on record	Aug 28, 2025	Sell	-10,494	1.80 USD	$18.9K	SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-267,541	—	—	SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-42,200	—	—	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 6, 2025	AwardD (derivative)	42,200	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	OtherD (derivative)	-152,700	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	AwardD (derivative)	16,901	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	AwardD (derivative)	152,700	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	Award	132,000	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	OtherD (derivative)	-394,445	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	OtherD (derivative)	-16,901	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	AwardD (derivative)	394,445	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	AwardD (derivative)	152,700	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Feb 26, 2025	OtherD (derivative)	-152,700	0.00 USD	—	SEC
Verve Therapeutics, Inc.Listing unverified	Jun 28, 2024	AwardD (derivative)	267,541	0.00 USD	—	SEC
Q32 Bio Inc.Listing on record	Mar 27, 2024	AwardD (derivative)	394,445	0.00 USD	—	SEC
AMERICAN LEARNING CorpListing unverified	Jun 17, 2022	AwardD (derivative)	54,500	0.00 USD	—	SEC
AMERICAN LEARNING CorpListing unverified	Jun 17, 2021	AwardD (derivative)	96,000	0.00 USD	—	SEC
AMERICAN LEARNING CorpListing unverified	Jun 18, 2020	AwardD (derivative)	12,500	0.00 USD	—	SEC
AMERICAN LEARNING CorpListing unverified	Jun 21, 2019	AwardD (derivative)	25,000	0.00 USD	—	SEC
Akebia Therapeutics, Inc.Listing on record	Jun 10, 2019	AwardD (derivative)	20,100	0.00 USD	—	SEC